[{"@context":"https://schema.org","@type":"Article","headline":"🧬RSV呼吸道合胞病毒高危\n50歲以上心血管患者高危¹🩺","image":["https://cloudapp01.ulifestyle.com.hk/post/600-2345-2931-CR-1-RB-1/post_1761229214548.jpeg","https://cloudapp01.ulifestyle.com.hk/post/600-2345-2931-CR-1-RB-1/post_1761229214929.jpeg"],"datePublished":"2025-10-23 22:21:02+08:00","url":"/community/detailpost/957254de-95f8-454b-a750-9d92c3b0556d/生活/rsv呼吸道合胞病毒/lammjoycec/277479","author":{"@type":"Person","name":"lammjoycec","url":"https://www.ulifestyle.com.hk/community/user_profile/277479/lammjoycec"},"text":"🧬RSV呼吸道合胞病毒高危\n50歲以上心血管患者高危¹🩺\n\n早前適逄世界心臟日，我參加左商場舉辦的世界心臟月展覽，認識到50歲以上心血管患者屬RSV呼吸道合胞病毒高危。¹作為照顧者嘅我都好緊張呢件事，因為父母都年長了🧓🏻👴🏻\n\n原來感染50歲以上心血管患者感染RSV可影響心臟健康，RSV屬高傳染性，每名感染者平均能將病毒傳播給3人¹⁻³😲如果感染進展至下呼吸道感染，可引致肺炎、住院、死亡, RSV感染的死亡率較流感高，無特效藥，只可靠接種疫苗預防💉如果同時感染RSV及流感，死亡比例增加4倍，所以真係要好好預防！¹⁻⁸ * †\n\n各位今年陪你父母接種流感疫苗既時候，記得幫佢地問下醫生RSV疫苗及預防方案啦🩺\n\n了解更多 https://www.rsv.hk/zh-hk/\n\n#RSV #呼吸道合胞病毒 #長期病患 #糖尿病 #心臟病 #哮喘 #慢阻肺病 #肺炎 #心臟衰竭\n\n請向醫生查詢有關詳情。\n\n*在因呼吸道疾病而需住院治療的患者當中,RSV的60天死亡率為17.6%,比甲型流感的7.5%為高\n†一項於2017至2019年進行的回溯研究,分析因感染RSV、流感或雙重感染而住院的成人患者的臨床結果\n \n\n \nReferences:\n1.\tMelgar M, Roper L, Britton A, et al. Evidence to Recommendations Framework (EtR): RSV Vaccination in Adults Aged 50–59 Years, 60–74 Years, and 75 Years and Older. Centers for Disease Control and Prevention; 2024. https://www.cdc.gov/acip/downloads/slides- 2024-06-26-28/11-RSV-Adult-Melgar-Roper-Britton-508.pdf. Accessed October 2025\n2. Reis J, Shaman J. Retrospective parameter estimation and forecast of respiratory\nsyncytial virus in the United States. PLoS Comput Biol. 2016;12(10):e1005133.\n3.\tFranczuk P. et al. Biomedicines 2022(1)71.\n4.\tKodama, F., Nace, D. A., Jump, R. L. P., et al. (2017). Respiratory syncytial virus and other noninfluenza respiratory viruses in older adults. Infectious Disease Clinics of North America, 31(4), 767–790.\n5.\tZhang Y et al. Influenza Other Respir Viruses 202;14;483-490.\n6.\tCDC. Respiratory syncytial virus (RSV): RSV in adults. 2025. Available https://www.cdc.gov/rsv/adults/index.html. Accessed October 2025.\n7.\tTseng HF, et al. J Infect Dis. 2020;222(8);1298-1310. https://www.cdc.gov/acip/downloads/slides-2024-06-26-28/11-RSV-Adult-Melgar-Roper-Britton-508.pdf. Accessed October 2025.\n8.\tFranczuk P, et al. Biomedicines. 2022;11(1):71.\n© 2025 葛蘭素史克集團或其授權人 \nNP-HK-VX-SMP-250016 (12/26) \nDate of Preparation: 10/2025"},{"@context":"https://schema.org","@type":"DiscussionForumPosting","headline":"🧬RSV呼吸道合胞病毒高危\n50歲以上心血管患者高危¹🩺","image":["https://cloudapp01.ulifestyle.com.hk/post/600-2345-2931-CR-1-RB-1/post_1761229214548.jpeg","https://cloudapp01.ulifestyle.com.hk/post/600-2345-2931-CR-1-RB-1/post_1761229214929.jpeg"],"datePublished":"2025-10-23 22:21:02+08:00","url":"/community/detailpost/957254de-95f8-454b-a750-9d92c3b0556d/生活/rsv呼吸道合胞病毒/lammjoycec/277479","author":{"@type":"Person","name":"lammjoycec","url":"https://www.ulifestyle.com.hk/community/user_profile/277479/lammjoycec"},"text":"🧬RSV呼吸道合胞病毒高危\n50歲以上心血管患者高危¹🩺\n\n早前適逄世界心臟日，我參加左商場舉辦的世界心臟月展覽，認識到50歲以上心血管患者屬RSV呼吸道合胞病毒高危。¹作為照顧者嘅我都好緊張呢件事，因為父母都年長了🧓🏻👴🏻\n\n原來感染50歲以上心血管患者感染RSV可影響心臟健康，RSV屬高傳染性，每名感染者平均能將病毒傳播給3人¹⁻³😲如果感染進展至下呼吸道感染，可引致肺炎、住院、死亡, RSV感染的死亡率較流感高，無特效藥，只可靠接種疫苗預防💉如果同時感染RSV及流感，死亡比例增加4倍，所以真係要好好預防！¹⁻⁸ * †\n\n各位今年陪你父母接種流感疫苗既時候，記得幫佢地問下醫生RSV疫苗及預防方案啦🩺\n\n了解更多 https://www.rsv.hk/zh-hk/\n\n#RSV #呼吸道合胞病毒 #長期病患 #糖尿病 #心臟病 #哮喘 #慢阻肺病 #肺炎 #心臟衰竭\n\n請向醫生查詢有關詳情。\n\n*在因呼吸道疾病而需住院治療的患者當中,RSV的60天死亡率為17.6%,比甲型流感的7.5%為高\n†一項於2017至2019年進行的回溯研究,分析因感染RSV、流感或雙重感染而住院的成人患者的臨床結果\n \n\n \nReferences:\n1.\tMelgar M, Roper L, Britton A, et al. Evidence to Recommendations Framework (EtR): RSV Vaccination in Adults Aged 50–59 Years, 60–74 Years, and 75 Years and Older. Centers for Disease Control and Prevention; 2024. https://www.cdc.gov/acip/downloads/slides- 2024-06-26-28/11-RSV-Adult-Melgar-Roper-Britton-508.pdf. Accessed October 2025\n2. Reis J, Shaman J. Retrospective parameter estimation and forecast of respiratory\nsyncytial virus in the United States. PLoS Comput Biol. 2016;12(10):e1005133.\n3.\tFranczuk P. et al. Biomedicines 2022(1)71.\n4.\tKodama, F., Nace, D. A., Jump, R. L. P., et al. (2017). Respiratory syncytial virus and other noninfluenza respiratory viruses in older adults. Infectious Disease Clinics of North America, 31(4), 767–790.\n5.\tZhang Y et al. Influenza Other Respir Viruses 202;14;483-490.\n6.\tCDC. Respiratory syncytial virus (RSV): RSV in adults. 2025. Available https://www.cdc.gov/rsv/adults/index.html. Accessed October 2025.\n7.\tTseng HF, et al. J Infect Dis. 2020;222(8);1298-1310. https://www.cdc.gov/acip/downloads/slides-2024-06-26-28/11-RSV-Adult-Melgar-Roper-Britton-508.pdf. Accessed October 2025.\n8.\tFranczuk P, et al. Biomedicines. 2022;11(1):71.\n© 2025 葛蘭素史克集團或其授權人 \nNP-HK-VX-SMP-250016 (12/26) \nDate of Preparation: 10/2025"},{"@context":"https://schema.org","@type":"ImageObject","contentUrl":"https://cloudapp01.ulifestyle.com.hk/post/600-2345-2931-CR-1-RB-1/post_1761229214548.jpeg","creator":{"@type":"Person","name":"lammjoycec"}}]

🧬RSV呼吸道合胞病毒高危 50歲以上心血管患者高危¹🩺